Alerus Financial’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-13,615
Closed -$1.94M 200
2021
Q3
$1.94M Buy
13,615
+384
+3% +$56.5K 0.18% 116
2021
Q2
$2.07M Buy
13,231
+3,767
+40% +$610K 0.21% 108
2021
Q1
$1.47M Buy
9,464
+3,001
+46% +$465K 0.16% 123
2020
Q4
$967K Buy
+6,463
New +$913K 0.1% 133
2020
Q1
Sell
-3,261
Closed -$474K 165
2019
Q4
$474K Buy
+3,261
New +$450K 0.05% 130
2019
Q3
Sell
-1,926
Closed -$220K 158
2019
Q2
$220K Buy
1,926
+142
+8% +$16.6K 0.03% 144
2019
Q1
$221K Sell
1,784
-2,958
-62% -$336K 0.03% 139
2018
Q4
$477K Sell
4,742
-13,766
-74% -$1.55M 0.07% 112
2018
Q3
$2.36M Sell
18,508
-672
-4% -$79.9K 0.32% 81
2018
Q2
$2.08M Buy
19,180
+197
+1% +$21.4K 0.29% 87
2018
Q1
$2.01M Sell
18,983
-14,111
-43% -$1.64M 0.29% 87
2017
Q4
$3.88M Sell
33,094
-940
-3% -$106K 0.55% 55
2017
Q3
$3.87M Buy
34,034
+414
+1% +$47.8K 0.56% 55
2017
Q2
$4.19M Sell
33,620
-304
-0.9% -$36K 0.62% 49
2017
Q1
$4.02M Buy
33,924
+225
+0.7% +$25.5K 0.62% 47
2016
Q4
$3.38M Buy
33,699
+2,873
+9% +$308K 0.55% 56
2016
Q3
$3.89M Sell
30,826
-7,024
-19% -$868K 0.63% 51
2016
Q2
$4.42M Buy
+37,850
New +$4.28M 0.74% 47

Other funds holding ZBH

Alerus Financial's ZBH Position: Q4 2021 in Review

Alerus Financial sold out of Zimmer Biomet (ZBH) in Q4 2021, closing a stake of 13,615 shares — an estimated $1.94M sold.

Alerus Financial first reported a position in ZBH in Q2 2016 and held it in 18 quarters. The position peaked at $4.42M in Q2 2016. 998 funds tracked by Wall St. Rank hold ZBH as of Q4 2021.

  • Alerus Financial reported no remaining Zimmer Biomet position as of Q4 2021 after selling out during the quarter.
  • Alerus Financial sold 13,615 Zimmer Biomet shares in Q4 2021, an estimated $1.94M.
  • Alerus Financial first reported a position in Zimmer Biomet in Q2 2016 and held it in 18 quarters.
  • Alerus Financial's Zimmer Biomet position peaked at $4.42M in Q2 2016.
  • 998 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2021.

Based on Alerus Financial's 13F filing for Q4 2021, filed 14 Feb 2022.